Micro-CT imaging assessment of dobutamine-induced cardiac stress in rats.
BACKGROUND
Dobutamine (DOB) stress in animal models of heart disease has been imaged so far using echocardiography and magnetic resonance imaging. The purpose of this study was to assess normal response to DOB stress in rats using anatomical and functional data using micro-computed tomography (CT).


METHODS
Ten normal adult male rats were first injected with a liposomal-based blood pool contrast agent and next infused with DOB via a tail vein catheter. Using prospective gating, 5 pairs of systole/diastole micro-CT images were acquired (a) pre-infusion baseline; (b) at heart rate plateau during infusion of 10 μg/kg/min DOB; (c) at post-DOB infusion baseline; (d) at heart rate plateau during infusion of 30 μg/kg/min DOB; and (e) after post-infusion return to baseline. Heart rate, peripheral and breathing distensions were monitored by oximetry. Micro-CT images with 88-μm isotropic voxels were segmented to obtain cardiac function based on volumetric measurements of the left ventricle.


RESULTS
DOB stress increased heart rate and cardiac output with both doses. Ejection fraction increased above baseline by an average of 35.9% with the first DOB dose and 18.4% with the second dose. No change was observed in the relative peripheral arterial pressures associated with the significant increases in cardiac output.


CONCLUSIONS
Micro-CT proved to be a robust imaging method able to provide isotropic data on cardiac morphology and function. Micro-CT has the advantage of being faster and more cost-effective than MR and is able to provide higher accuracy than echocardiography. The impact of such an enabling technology can be enormous in evaluating cardiotoxic effects of various test drugs.
Badea
Cristian T
CT
Center for In Vivo Microscopy, Department of Radiology, Box 3302 Duke University Medical Center, Durham, NC 27710, USA. cristian.badea@duke.edu
Hedlund
Laurence W
LW
Cook
James
J
Berridge
Brian R
BR
Johnson
G Allan
GA
D000818:Animals; D002302:Cardiac Output / Q000187:drug effects*; D004280:Dobutamine / Q000008:administration & dosage / Q000494:pharmacology*; D004452:Echocardiography; D004562:Electrocardiography; D006321:Heart / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013312:Stress, Physiological; D055114:X-Ray Microtomography / Q000379:methods*
D004280:Dobutamine
Magn Reson Med. 1998 Jul;40(1):43-8
9660551
Magn Reson Med. 2008 Jul;60(1):111-8
18581419
Am J Physiol. 1998 Feb;274(2):H679-83
9486274
J Cardiovasc Magn Reson. 2008 Nov 03;10:48
18980685
Invest Radiol. 2007 Feb;42(2):85-94
17220726
Magn Reson Med. 1998 Jun;39(6):980-7
9621922
Mol Imaging. 2007 Jul-Aug;6(4):261-8
17711781
Echocardiography. 2003 Jan;20(1):47-55
12848697
J Magn Reson Imaging. 2009 Aug;30(2):466-71
19629999
AJR Am J Roentgenol. 2006 Feb;186(2):300-7
16423931
J Pharmacol Exp Ther. 2008 Apr;325(1):331-40
18171907
Am J Vet Res. 1998 Sep;59(9):1160-5
9736396
Med Phys. 2008 Apr;35(4):1170-9
18491508
Med Phys. 2007 Nov;34(11):4476-83
18072512
Am J Physiol Heart Circ Physiol. 2000 Feb;278(2):H652-7
10666098
J Magn Reson Imaging. 2001 Nov;14(5):547-55
11747006
Mol Imaging. 2005 Apr-Jun;4(2):110-6
16105509
J Nucl Med. 2003 Oct;44(10):1662
14530483
Proc SPIE Int Soc Opt Eng. 2008 Apr 18;6913:691342
22049304
Eur Heart J. 1997 Jun;18 Suppl D:D9-15
9183605
J Magn Reson Imaging. 2004 Jul;20(1):31-8
15221806
Cardiovasc Ultrasound. 2005 Oct 26;3:34
16250913
Res Vet Sci. 1996 Nov;61(3):234-9
8938854